common.study.topics.clinical

DNA-Repair Defects in Men with Metastatic Prostate Cancer

common.study.values.description

A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

The purpose of this study is to evaluate the prevalence of 4 or more DNA-repair defects in a population of men with metastatic Prostate Cancer (PC) and to use the variants reported to assess biomarker eligibility for niraparib interventional studies.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Recruiting patients only common.study.methods.is-healthy-yes

Saliva, Blood, or Existing Tissue Sample Collection and Analysis

Saliva or blood sample (or both) or existing tissue sample analysis will be collected from the participants with metastatic PC for genetic testing to determine if DNA-repair defects are present.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Biomarker Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

common.study.values.clinical-trial-id

NCT03871816

participant.views.study.view.id

bDkx5a